• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于日本 ADAMTS13 基因分析的 Upshaw-Schulman 综合征自然史。

Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan.

机构信息

Department of Blood Transfusion Medicine, Nara Medical University, Nara, Japan.

出版信息

J Thromb Haemost. 2011 Jul;9 Suppl 1:283-301. doi: 10.1111/j.1538-7836.2011.04341.x.

DOI:10.1111/j.1538-7836.2011.04341.x
PMID:21781265
Abstract

Upshaw-Schulman syndrome (USS) is an extremely rare hereditary deficiency of ADAMTS13 activity, termed congenital TTP. The clinical signs are usually mild during childhood, often with isolated thrombocytopenia. But their symptoms become more evident when patients have infections or get pregnant. We identified 43 USS-patients in Japan, who ranged in age from early childhood to 79 years of age. Analysing the natural history of these USS patients based on ADAMTS13 gene mutations may help characterise their clinical phenotypes. Severe neonatal jaundice that requires exchange blood transfusion, a hallmark of USS, was found in 18 of 43 patients (42%). During childhood, 25 of 43 patients were correctly diagnosed with USS without gender disparity. These 25 patients were categorised as having 'the early-onset phenotype'. Between 15 and 45 years of age, 15 were correctly diagnosed, and, interestingly, they were all female. The remaining three patients were male and were diagnosed when they were older than 45 years of age, suggesting that they were 'the late-onset phenotype'. Two of these three males developed sudden overt TTP when they were 55 and 63 years old, respectively. These two men had two different homozygous ADAMTS13 gene mutations, p.R193W/p.R193W and p.C1024R/p.C1024R, respectively. Both of which were not discovered in the US or Western countries. In vitro expression studies showed that these two proteins were consistently secreted into the culture medium but to a lesser extent and with reduced activity compared to the wild-type protein. Our results indicate that 'the late-onset phenotype' of USS is formed with ethnic specificity.

摘要

乌绍-舒尔曼综合征(Upshaw-Schulman syndrome,USS)是一种极其罕见的 ADAMTS13 活性遗传性缺乏症,称为先天性 TTP。儿童期的临床症状通常较轻,常伴有孤立性血小板减少症。但当患者感染或怀孕时,其症状会更加明显。我们在日本鉴定了 43 名 USS 患者,年龄从幼儿到 79 岁不等。分析这些 USS 患者基于 ADAMTS13 基因突变的自然病史可能有助于描述其临床表型。需要换血的严重新生儿黄疸是 USS 的特征之一,在 43 名患者中有 18 名(42%)发现。在儿童期,43 名患者中有 25 名被正确诊断为 USS,且无性别差异。这些 25 名患者被归类为具有“早发型表型”。在 15 至 45 岁之间,有 15 名患者被正确诊断,有趣的是,他们都是女性。其余三名患者是男性,且在 45 岁以上被诊断出,提示他们具有“晚发型表型”。这三名男性中的两名在 55 岁和 63 岁时分别突然出现明显的 TTP。这两名男性分别携带两种不同的纯合 ADAMTS13 基因突变,p.R193W/p.R193W 和 p.C1024R/p.C1024R,均未在美欧国家发现。体外表达研究表明,这两种蛋白质都持续分泌到培养基中,但程度较轻,且与野生型蛋白相比活性降低。我们的结果表明,USS 的“晚发型表型”具有种族特异性。

相似文献

1
Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan.基于日本 ADAMTS13 基因分析的 Upshaw-Schulman 综合征自然史。
J Thromb Haemost. 2011 Jul;9 Suppl 1:283-301. doi: 10.1111/j.1538-7836.2011.04341.x.
2
Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients.妊娠合并血小板减少症和血栓性血小板减少性紫癜,以及厄普肖 - 舒尔曼综合征中的胎儿死亡风险:9例基因分型患者的15次妊娠系列研究
Br J Haematol. 2009 Mar;144(5):742-54. doi: 10.1111/j.1365-2141.2008.07515.x. Epub 2008 Nov 26.
3
Paradigm shift of childhood thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency.伴有严重ADAMTS13缺乏的儿童血栓性血小板减少性紫癜的范式转变。
Presse Med. 2012 Mar;41(3 Pt 2):e137-55. doi: 10.1016/j.lpm.2011.10.027. Epub 2012 Jan 20.
4
ADAMTS13 Gene Mutations Influence ADAMTS13 Conformation and Disease Age-Onset in the French Cohort of Upshaw-Schulman Syndrome.ADAMTS13 基因突变影响法国 Upshaw-Schulman 综合征队列中 ADAMTS13 构象和发病年龄。
Thromb Haemost. 2018 Nov;118(11):1902-1917. doi: 10.1055/s-0038-1673686. Epub 2018 Oct 12.
5
The homozygous p.C1024R- ADAMTS13 gene mutation links to a late-onset phenotype of Upshaw-Schulman syndrome in Japan.纯合子p.C1024R - ADAMTS13基因突变与日本Upshaw - Schulman综合征的迟发性表型相关。
Thromb Haemost. 2012 May;107(5):1003-5. doi: 10.1160/TH11-11-0799. Epub 2012 Mar 8.
6
Complement activation associated with ADAMTS13 deficiency may contribute to the characteristic glomerular manifestations in Upshaw-Schulman syndrome.补体激活与 ADAMTS13 缺乏相关,可能导致 Ussawa-Schulman 综合征的特征性肾小球表现。
Thromb Res. 2018 Oct;170:148-155. doi: 10.1016/j.thromres.2018.08.020. Epub 2018 Sep 1.
7
Novel ADAMTS13 mutations in an obstetric patient with Upshaw-Schulman syndrome.一名患有Upshaw-Schulman综合征的产科患者的新型ADAMTS13突变
J Clin Apher. 2013 Aug;28(4):311-6. doi: 10.1002/jca.21251. Epub 2012 Dec 3.
8
Two newborn-onset patients of Upshaw-Schulman syndrome with distinct subsequent clinical courses.两例新生儿起病的 Upshaw-Schulman 综合征患者,其后的临床病程明显不同。
Int J Hematol. 2012 Dec;96(6):789-97. doi: 10.1007/s12185-012-1221-8. Epub 2012 Nov 28.
9
ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura.ADAMTS13 突变和多态性与先天性血栓性血小板减少性紫癜。
Hum Mutat. 2010 Jan;31(1):11-9. doi: 10.1002/humu.21143.
10
Case of maternal and fetal deaths due to severe congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) during pregnancy.孕期因严重先天性血栓性血小板减少性紫癜(乌-舒二氏综合征)导致母婴死亡的病例。
J Obstet Gynaecol Res. 2014 Jan;40(1):247-9. doi: 10.1111/jog.12125. Epub 2013 Aug 12.

引用本文的文献

1
Congenital thrombotic thrombocytopenic purpura: a rare cause of severe neonatal jaundice and hypoxic respiratory failure - a case report.先天性血栓性血小板减少性紫癜:严重新生儿黄疸和缺氧性呼吸衰竭的罕见病因——病例报告
Case Rep Perinat Med. 2025 Jul 9;14(1):20240050. doi: 10.1515/crpm-2024-0050. eCollection 2025 Jan.
2
Thrombotic Thrombocytopenic Purpura in Pediatric Patients.儿童患者的血栓性血小板减少性紫癜
Biomedicines. 2025 Apr 25;13(5):1038. doi: 10.3390/biomedicines13051038.
3
Clarifying the role of p.Gln723Lys in hTTP prevalence.
阐明p.Gln723Lys在人血栓性血小板减少性紫癜(hTTP)患病率中的作用。
Blood Adv. 2025 Jun 24;9(12):3024-3025. doi: 10.1182/bloodadvances.2025016030.
4
Fatal interplay between acquired thrombotic thrombocytopenic purpura and posterior reversible encephalopathy syndrome: a case report.获得性血栓性血小板减少性紫癜与后部可逆性脑病综合征之间的致命相互作用:一例报告
Radiol Case Rep. 2025 Mar 27;20(6):2995-2999. doi: 10.1016/j.radcr.2025.02.094. eCollection 2025 Jun.
5
Animal models for thrombotic thrombocytopenic purpura: a narrative review.血栓性血小板减少性紫癜的动物模型:一项叙述性综述。
Ann Blood. 2023 Sep 30;8. doi: 10.21037/aob-22-18. Epub 2022 Nov 16.
6
Global prevalence of hereditary thrombotic thrombocytopenic purpura determined by genetic analysis.通过基因分析确定遗传性血栓性血小板减少性紫癜的全球患病率。
Blood Adv. 2024 Aug 27;8(16):4386-4396. doi: 10.1182/bloodadvances.2024013421.
7
Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpura.新兴遗传性血栓性血小板减少性紫癜治疗方法的作用新机制。
Expert Rev Hematol. 2024 Jul;17(7):341-351. doi: 10.1080/17474086.2024.2356763. Epub 2024 May 20.
8
How We Interpret Thrombosis with Thrombocytopenia Syndrome?我们如何解读血栓性血小板减少性紫癜?
Int J Mol Sci. 2024 May 1;25(9):4956. doi: 10.3390/ijms25094956.
9
Hereditary TTP/Upshaw-Schulman syndrome: the ductus arteriosus controls newborn survival.遗传性 TTP/Upshaw-Schulman 综合征:动脉导管控制新生儿的生存。
Int J Hematol. 2024 May;119(5):532-540. doi: 10.1007/s12185-024-03731-1. Epub 2024 Mar 27.
10
Targeting neutrophil extracellular trap accumulation under flow in patients with immune-mediated thrombotic thrombocytopenic purpura.靶向免疫介导性血栓性血小板减少性紫癜患者血流中中性粒细胞胞外诱捕网的积聚。
Blood Adv. 2024 May 28;8(10):2536-2551. doi: 10.1182/bloodadvances.2023011617.